3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Weight Loss
1
Pancreatic Neoplasms
1
Disease
1
Cachexia
1
Adenocarcinoma
1
Interventions
Blood Specimen Collection
9
Surveys and Questionnaires
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
Prednisone
4
Colonoscopy
4
Biopsy, Fine-Needle
4
Tomography, X-Ray Computed
3
Surgical Procedures, Operative
3
Mammography
3
Magnetic Resonance Imaging
3
Liquid Biopsy
3
Lenalidomide
3
Interviews as Topic
3
Exercise
3
Diagnostic Tests, Routine
3
Cyclophosphamide
3
weifuchun
2
pembrolizumab
2
obinutuzumab
2
Urination
2
Preoperative Exercise
2
Positron Emission Tomography Computed Tomography
2
Observation
2
Methods
2
Melphalan
2
Immunohistochemistry
2
Hematologic Tests
2
Gemcitabine
2
Educational Status
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Disease
×
bermekimab
×
Clear all
NCT03207724
2020-12-30
OnFX
Cedars-Sinai Medical Center
Phase 1
Completed
16 enrolled